Quest Diagnostics Total Long Term Liabilities 2010-2025 | DGX
Quest Diagnostics total long term liabilities from 2010 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Quest Diagnostics total long term liabilities for the quarter ending March 31, 2025 were $7.394B, a 42.55% increase year-over-year.
- Quest Diagnostics total long term liabilities for 2024 were $7.171B, a 22.27% increase from 2023.
- Quest Diagnostics total long term liabilities for 2023 were $5.865B, a 9.5% increase from 2022.
- Quest Diagnostics total long term liabilities for 2022 were $5.356B, a 0.35% decline from 2021.
Quest Diagnostics Annual Total Long Term Liabilities
(Millions of US $) |
| 2024 |
$7,171 |
| 2023 |
$5,865 |
| 2022 |
$5,356 |
| 2021 |
$5,375 |
| 2020 |
$5,441 |
| 2019 |
$5,166 |
| 2018 |
$4,251 |
| 2017 |
$4,491 |
| 2016 |
$4,459 |
| 2015 |
$4,076 |
| 2014 |
$3,818 |
| 2013 |
$3,843 |
| 2012 |
$4,050 |
| 2011 |
$4,037 |
| 2010 |
$3,259 |
| 2009 |
$3,493 |
Quest Diagnostics Quarterly Total Long Term Liabilities
(Millions of US $) |
| 2025-03-31 |
$7,394 |
| 2024-12-31 |
$7,171 |
| 2024-09-30 |
$7,162 |
| 2024-06-30 |
$5,213 |
| 2024-03-31 |
$5,187 |
| 2023-12-31 |
$5,865 |
| 2023-09-30 |
$5,401 |
| 2023-06-30 |
$5,263 |
| 2023-03-31 |
$5,351 |
| 2022-12-31 |
$5,356 |
| 2022-09-30 |
$5,349 |
| 2022-06-30 |
$5,285 |
| 2022-03-31 |
$5,327 |
| 2021-12-31 |
$5,375 |
| 2021-09-30 |
$5,381 |
| 2021-06-30 |
$5,370 |
| 2021-03-31 |
$5,434 |
| 2020-12-31 |
$5,441 |
| 2020-09-30 |
$5,308 |
| 2020-06-30 |
$5,266 |
| 2020-03-31 |
$5,217 |
| 2019-12-31 |
$5,166 |
| 2019-09-30 |
$4,354 |
| 2019-06-30 |
$4,347 |
| 2019-03-31 |
$4,314 |
| 2018-12-31 |
$4,251 |
| 2018-09-30 |
$4,232 |
| 2018-06-30 |
$4,222 |
| 2018-03-31 |
$4,512 |
| 2017-12-31 |
$4,491 |
| 2017-09-30 |
$4,559 |
| 2017-06-30 |
$4,521 |
| 2017-03-31 |
$4,461 |
| 2016-12-31 |
$4,459 |
| 2016-09-30 |
$4,433 |
| 2016-06-30 |
$4,429 |
| 2016-03-31 |
$4,341 |
| 2015-12-31 |
$4,076 |
| 2015-09-30 |
$4,320 |
| 2015-06-30 |
$4,134 |
| 2015-03-31 |
$4,253 |
| 2014-12-31 |
$3,818 |
| 2014-09-30 |
$4,401 |
| 2014-06-30 |
$4,380 |
| 2014-03-31 |
$4,338 |
| 2013-12-31 |
$3,843 |
| 2013-09-30 |
$3,817 |
| 2013-06-30 |
$3,807 |
| 2013-03-31 |
$3,871 |
| 2012-12-31 |
$4,050 |
| 2012-09-30 |
$4,051 |
| 2012-06-30 |
$4,047 |
| 2012-03-31 |
$4,030 |
| 2011-12-31 |
$4,037 |
| 2011-09-30 |
$4,017 |
| 2011-06-30 |
$3,987 |
| 2011-03-31 |
$4,220 |
| 2010-12-31 |
$3,259 |
| 2010-09-30 |
$3,430 |
| 2010-06-30 |
$3,539 |
| 2010-03-31 |
$3,510 |
| 2009-12-31 |
$3,493 |
| 2009-09-30 |
$3,437 |
| 2009-06-30 |
$3,422 |
| 2009-03-31 |
$3,548 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-OUTP/HM CRE |
$19.866B |
$9.872B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
